Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Quarterly i.v. Bonviva injection recommended for approval in Europe

Jan. 30, 2006

Positive opinion for Myozyme for Pompe disease in Europe

Jan. 30, 2006

Exubera approved in Europe and the U.S.

Jan. 30, 2006

Eculizumab arrests chronic intravascular hemolysis in PNH patients

Jan. 30, 2006

Fast track designation for Phenoptin in PKU

Jan. 30, 2006

Recent patents report novel agents for obesity and lipoprotein disorders

Jan. 27, 2006

NeuroSearch to continue development of tesofensine

Jan. 27, 2006

Metaglidasen as effective as thiazolidinediones for glycemic control

Jan. 27, 2006

New GPR109b agonists as antilipolytic agents

Jan. 27, 2006

Novel agents for treating endocrine-related disorders disclosed in recent patents

Jan. 26, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...